These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26686256)

  • 21. Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia.
    Hosman A; Westermann CJ; Snijder R; Disch F; Mummery CL; Mager JJ
    Rhinology; 2015 Dec; 53(4):340-4. PubMed ID: 26735132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Layton KF; Kallmes DF; Gray LA; Cloft HJ
    AJNR Am J Neuroradiol; 2007 May; 28(5):885-8. PubMed ID: 17494663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.
    Iyer VN; Apala DR; Pannu BS; Kotecha A; Brinjikji W; Leise MD; Kamath PS; Misra S; Begna KH; Cartin-Ceba R; DuBrock HM; Krowka MJ; O'Brien EK; Pruthi RK; Schroeder DR; Swanson KL
    Mayo Clin Proc; 2018 Feb; 93(2):155-166. PubMed ID: 29395350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silicone septal splint for recurrent epistaxis in HHT patients: experience of a national referral centre.
    Matti E; Maiorano E; Nacu B; Luceri A; Sovardi F; Siragusa V; Ferrauto A; Spinozzi G; Olivieri C; Benazzo M; Pagella F
    Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S28-S33. PubMed ID: 37698097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study.
    Kroon S; Snijder RJ; Hosman AE; Vorselaars VMM; Disch FJM; Post MC; Mager JJ
    Angiogenesis; 2021 May; 24(2):379-386. PubMed ID: 33211216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Donato M; Pimentel J; Cabral R; Escada P
    Acta Med Port; 2018 Jan; 31(1):63-66. PubMed ID: 29573771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. North American Study for the Treatment of Recurrent Epistaxis with Doxycycline: The NOSTRIL trial.
    McWilliams JP; Majumdar S; Kim GH; Lee J; Seals K; Tangchaiburana S; Gilbert S; Duckwiler GR
    J Thromb Haemost; 2022 May; 20(5):1115-1125. PubMed ID: 35108451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Chanan-Khan AA; Zaritskey A; Egyed M; Vokurka S; Semochkin S; Schuh A; Kassis J; Simpson D; Zhang J; Purse B; Foà R
    Lancet Haematol; 2017 Nov; 4(11):e534-e543. PubMed ID: 28958469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
    Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
    J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
    Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
    J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Lennox PA; Harries M; Lund VJ; Howard DJ
    J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.
    Lebrin F; Srun S; Raymond K; Martin S; van den Brink S; Freitas C; Bréant C; Mathivet T; Larrivée B; Thomas JL; Arthur HM; Westermann CJ; Disch F; Mager JJ; Snijder RJ; Eichmann A; Mummery CL
    Nat Med; 2010 Apr; 16(4):420-8. PubMed ID: 20364125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
    Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME
    Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F
    MAbs; 2014; 6(3):794-9. PubMed ID: 24481211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.
    Contis A; Gensous N; Viallard JF; Goizet C; Léauté-Labrèze C; Duffau P
    Clin Otolaryngol; 2017 Aug; 42(4):911-917. PubMed ID: 28032956
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
    de Jel DVC; Disch FJM; Kroon S; Mager JJ; Verdam FJ
    Angiogenesis; 2020 Aug; 23(3):271-274. PubMed ID: 32112177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
    Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
    Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.